Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
CC transcript
Asset disposition
Inv. presentation
HARVARD BIOSCIENCE INC (HBIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Q2 Revenues of $28.8 million"
04/26/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/05/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/13/2023 8-K Other Events  Interactive Data
03/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/09/2023 10-K Annual Report for the period ended December 31, 2022
03/09/2023 8-K Quarterly results
Docs: "Harvard Bioscience Announces Fourth Quarter 2022 Financial Results HOLLISTON, Mass., March 9, 2023"
02/14/2023 SC 13G Harvey Partners, LLC reports a 7% stake in HARVARD BIOSCIENCE, INC.
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/19/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "SEPARATION AGREEMENT AND RELEASE"
01/11/2023 SC 13G/A Leviticus Partners LP reports a 4.9% stake in HARVARD BIOSCIENCE INC
01/03/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Vice President, Finance"
12/21/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/12/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Harvard Bioscience Announces CFO Transition"
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
Docs: "Harvard Bioscience Announces Third Quarter 2022 Financial Results"
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
Docs: "Harvard Bioscience Announces Second Quarter 2022 Financial Results HOLLISTON, Mass., August 3, 2022"
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/21/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/08/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/20/2022 SD Form SD - Specialized disclosure report:
05/17/2022 8-K Quarterly results
05/04/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/04/2022 8-K Quarterly results
04/07/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/07/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/11/2022 10-K Annual Report for the period ended December 31, 2021
03/08/2022 8-K Quarterly results
02/14/2022 SC 13G PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. reports a 5.3% stake in Harvard Bioscience Inc.
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy